Recall: International Laboratories, LLC Pravastatin Sodium Tablets
On 2017-08-09, the FDA announced that International Laboratories is conducting a recall on Pravastatin Sodium Tablets due to a possible mislabeling. The recalled products were sold under the brand name(s) International Laboratories and LLC during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 1 drugs recalls due to potential mislabeling. Additionally, there have been 22 drug and medical device recalls due to other health hazards as well as 125 food recalls.
Company Contact Information:
Name: International Laboratories
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Arkansas, Alabama, Florida, Georgia, Iowa, Illinois, Indiana, Kansas, Kentucky, Louisiana, Michigan, Minnesota, Missouri, Mississippi, North Carolina, North Dakota, Nebraska, Ohio, Oklahoma, Puerto Rico, South Carolina, South Dakota, Tennessee, Texas, Virginia and Wisconsin
Product Description: Pravastatin Sodium Tablets
Brand Name(s): International Laboratories, LLC
Reason for Recall: Mislabeling
Official Recall Date: 2017-08-09
Additional information provided by the FDA.gov:
International Laboratories, LLC is voluntarily recalling one (1) Lot of Pravastatin Sodium Tablets USP 40 mg packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Pravastatin Sodium Tablets USP 40 mg but contained Bupropion Hydrochloride XL 300 mg tablets. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.